CAS 1346607-05-3

Formule : C26H20ClN3O5

InChI : InChI=1S/C26H20ClN3O5/c1-34-18-6-3-5-17(13-18)30-25(32)23-20(28-26(30)33)14-22(27)29(23)16-11-9-15(10-12-16)19-7-4-8-21(35-2)24(19)31/h3-14,31H,1-2H3,(H,28,33)

Code InChI : KURYSXLJGKKDHT-UHFFFAOYSA-N

SMILES : COC1=CC=CC(=C1)N2C(=O)C3=C(C=C(N3C4=CC=C(C=C4)C5=C(C(=CC=C5)OC)O)Cl)NC2=O

Gsk621

CAS : 1346607-05-3

Gsk621

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : 98+%

Masse moléculaire : 489.91

Ref: 54-OR1024378

GSK621

CAS : 1346607-05-3

GSK621

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : 97%

Masse moléculaire : 489.91

Ref: 54-BUP03201

6-Chloro-5-(2'-hydroxy-3'-methoxy-[1,1'-biphenyl]-4-yl)-3-(3-methoxyphenyl)-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione

CAS : 1346607-05-3

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 489.9071

Ref: IN-DA01ENTP

GSK621

CAS : 1346607-05-3

GSK621 is a specific and potent AMPK activator.

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : 97.02% - 97.05%

Couleur et forme : Solid

Masse moléculaire : 489.907

Ref: TM-T6854

GSK621

CAS : 1346607-05-3

6-Chloro-5-(2'-hydroxy-3'-methoxy-[1,1'-biphenyl]-4-yl)-3-(3-methoxyphenyl)-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : 98+%

Masse moléculaire : 489.91

Ref: IN-DG764852

GSK621

CAS : 1346607-05-3

GSK621 is a selective inhibitor, which is synthesized for research purposes in the modulation of enzymatic activity. This compound is sourced through synthetic chemical processes and designed to selectively target the phosphoinositide 3-kinase (PI3K) pathway. GSK621's mode of action involves the inhibition of the PI3K pathway, a critical signaling pathway involved in cellular functions such as growth, proliferation, and survival. By inhibiting this pathway, GSK621 can modulate aberrant signaling commonly observed in various cancers.

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : Min. 95%

Masse moléculaire : 489.91 g/mol

Ref: 3D-WDC60705